Current status of immunosuppressive agents for solid organ transplantation in children
書誌事項
- 公開日
- 2012-02-24
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1111/j.1399-3046.2012.01644.x
- 公開者
- Wiley
この論文をさがす
説明
<jats:p>Coelho T, Tredger M, Dhawan A. Current status of immunosuppressive agents for solid organ transplantation in children. Pediatr Transplantation 2012: 16: 106–122. © 2012 John Wiley & Sons A/S.</jats:p><jats:p><jats:bold>Abstract: </jats:bold>Immunosuppression after organ transplantation is complex and ever evolving. Over the past two decades, newer immunosuppressive agents have been introduced with an aim to provide better patient and graft survival. Improved therapeutic strategies have been developed offering the option to use combinations of drugs with non‐overlapping toxicities. There are, however, only a few clinical studies with robust data to rationalize the use of these agents in children. This review will discuss the newer immunosuppressive agents used for solid organ transplant, their current status in post‐transplant management and prevention of allograft rejection.</jats:p>
収録刊行物
-
- Pediatric Transplantation
-
Pediatric Transplantation 16 (2), 106-122, 2012-02-24
Wiley